Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolyn J Henry

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Infectious Diseases of Poverty|April 5, 2017
Malaria over-diagnosis in Cameroon: diagnostic accuracy of Fluorescence and Staining Technologies (FAST) Malaria Stain and LED microscopy versus Giemsa and bright field microscopy validated by polymerase chain reactionSean M Parsel, Steven A Gustafson, Edward Friedlander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinomaCarolyn J Henry, Dudley L McCaw, Susan E Turnquist, et al.
Neoplasia (New York, N.Y.)|September 6, 2007
Galectin-3 as a potential therapeutic target in tumors arising from malignant endotheliaKim D Johnson, Olga V Glinskii, Valeri V Mossine, et al.
International Journal of Nanomedicine|November 8, 2014
Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancerSandra M Axiak-Bechtel, Anandhi Upendran, Jimmy C Lattimer, et al.
Journal of Veterinary Internal Medicine|July 11, 2020
Autologous cancer cell vaccination, adoptive T-cell transfer, and interleukin-2 administration results in long-term survival for companion dogs with osteosarcomaBrian K Flesner, Gary W Wood, Pamela Gayheart-Walsten, et al.
American Journal of Veterinary Research|September 1, 2016
Phase I-II clinical trial of hyaluronan-cisplatin nanoconjugate in dogs with naturally occurring malignant tumorsShuang Cai, Ti Zhang, W C Forrest, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excisionCheryl A London, Phyllis B Malpas, Stacey L Wood-Follis, et al.
Plos One|April 30, 2015
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional StudyCheryl A London, Heather L Gardner, Tamra Mathie, et al.
Clinical and Translational Medicine|August 26, 2016
A One Health overview, facilitating advances in comparative medicine and translational researchCheryl Stroud, Igor Dmitriev, Elena Kashentseva, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Infectious Diseases of Poverty|April 5, 2017
Malaria over-diagnosis in Cameroon: diagnostic accuracy of Fluorescence and Staining Technologies (FAST) Malaria Stain and LED microscopy versus Giemsa and bright field microscopy validated by polymerase chain reactionSean M Parsel, Steven A Gustafson, Edward Friedlander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinomaCarolyn J Henry, Dudley L McCaw, Susan E Turnquist, et al.
Neoplasia (New York, N.Y.)|September 6, 2007
Galectin-3 as a potential therapeutic target in tumors arising from malignant endotheliaKim D Johnson, Olga V Glinskii, Valeri V Mossine, et al.
International Journal of Nanomedicine|November 8, 2014
Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancerSandra M Axiak-Bechtel, Anandhi Upendran, Jimmy C Lattimer, et al.
Journal of Veterinary Internal Medicine|July 11, 2020
Autologous cancer cell vaccination, adoptive T-cell transfer, and interleukin-2 administration results in long-term survival for companion dogs with osteosarcomaBrian K Flesner, Gary W Wood, Pamela Gayheart-Walsten, et al.
American Journal of Veterinary Research|September 1, 2016
Phase I-II clinical trial of hyaluronan-cisplatin nanoconjugate in dogs with naturally occurring malignant tumorsShuang Cai, Ti Zhang, W C Forrest, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excisionCheryl A London, Phyllis B Malpas, Stacey L Wood-Follis, et al.
Plos One|April 30, 2015
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional StudyCheryl A London, Heather L Gardner, Tamra Mathie, et al.
Clinical and Translational Medicine|August 26, 2016
A One Health overview, facilitating advances in comparative medicine and translational researchCheryl Stroud, Igor Dmitriev, Elena Kashentseva, et al.
Pageof 5